Rubraca(Rucaparib) Side Effects

Rubraca may cause a range of side effects, especially hematologic and gastrointestinal issues.

Side Effects of Rubraca

The most common side effects associated with Rubraca include hematologic abnormalities such as anemia, neutropenia, and thrombocytopenia, which may require dose reduction or discontinuation of treatment. Gastrointestinal issues such as nausea, fatigue, and decreased appetite have also been reported. Other less frequent but serious side effects may include liver enzyme elevation and myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) in some patients. Close monitoring of blood counts and liver function is essential during treatment with Rubraca to mitigate these risks. Specific rare side effects are not specified in the description.

Rucaparib(Rubraca)
Adult patients with BRCA-mutated advanced ovarian cancer who have previously failed second-line treatment drugs.
RELATED ARTICLES
The efficacy of Rucaparib

Rucaparib is a targeted therapy for specific genetic mutation diseases, mainly for BRCA mutation-associated...

Monday, June 23rd, 2025, 14:33
The role and efficacy of Rucaparib

Rucaparib is a drug used to treat specific types of diseases, primarily for recurrent ovarian disease and...

Monday, June 23rd, 2025, 14:21
Rucaparib Efficacy, side effects and precautions

Rucaparib, also known as Rubraca, is a PARP inhibitor used to treat BRCA mutation-associated recurrent ovarian...

Monday, June 23rd, 2025, 14:00
/ 1
3 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved